intercellular

(redirected from intercell)
Also found in: Thesaurus, Medical, Encyclopedia.

in·ter·cel·lu·lar

 (ĭn′tər-sĕl′yə-lər)
adj. Biology
Located among or between cells: intercellular fluid.

intercellular

(ˌɪntəˈsɛljʊlə) or

intercell

adj
(Biology) biology between or among cells: intercellular fluid.

in•ter•cel•lu•lar

(ˌɪn tərˈsɛl yə lər)

adj.
situated between or among cells.
[1825–35]

in·ter·cel·lu·lar

(ĭn′tər-sĕl′yə-lər)
Located between or among cells: intercellular fluid.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.intercellular - located between cells
biological science, biology - the science that studies living organisms
Translations

intercellular

adjinterzellular
References in periodicals archive ?
Intercell expects revenues and revenue recognition from existing technology partnerships to clearly exceed EUR 10m in the fourth quarter of 2008.
OTCBB:NMKT) independently listed its Chinese operations through the acquisition of Intercell International, Inc.
SeeNews) - Dec 18, 2012 - The planned merger between Austrian vaccine maker Intercell AG (WBAG:ICLL) and French biotech firm Vivalis SA (EPA:VLS) will not lead to significant job cuts as the two companies complement each other, Intercell CEO Thomas Lingelbach said on Monday.
17 December 2012 - French biopharmaceutical company Vivalis SA (EPA:VLS) and Austrian Austrian vaccine maker Intercell AG (VSE:ICLL) have agreed to combine in an all-stock deal to create Valneva, a European biotechnology firm focused on vaccines and antibodies, the pair said.
M2 EQUITYBITES-December 17, 2012-Vivalis, Intercell to merge into new company Valneva(C)2012 M2 COMMUNICATIONS http://www.
16 August 2011 - Austrian vaccine maker Intercell AG (WBAG:ICLL) announced today that it managed to cut its net loss to EUR1.
ADPnews) - Apr 11, 2011 - The shares of Austrian vaccine maker Intercell AG (WBAG:ICLL) dropped 27.
OTCBB:NMKT) announced today that the annual report for Intercell International Corp.
SeeNews) - Dec 17, 2012 - Austrian vaccine maker Intercell AG (WBAG:ICLL) and French biotech firm Vivalis SA (EPA:VLS) are merging to create a leading biotech vaccine maker in Europe, Intercell said on Sunday evening.
28 September 2011 - Austrian vaccine manufacturer Intercell AG (WBAG:ICLL) has entered into negotiations on the sale of a shareholding to a private equity investor, CEO Thomas Lingelbach told Bloomberg.
M2 EQUITYBITES-June 9, 2011-Merck and Intercell terminate study of investigational Staphylococcus aureus vaccine(C)2011 M2 COMMUNICATIONS http://www.
6 May 2011 - Austrian vaccine manufacturer Intercell AG (WBAG: ICLL) said yesterday its CEO Gerd Zettlmeissl will leave the firm.